Publications | PubMed=9023415; DOI=10.1006/cimm.1996.1062 Naoko Seki, Tomoaki Hoshino, Megumi Kikuchi, Akihiro Hayashi, Kyogo Itoh; HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer. Cell. Immunol. 175:101-110(1997) PubMed=9178645; DOI=10.1006/cimm.1997.1108 Masanobu Nakao, Michio Sata, Hideki Saitsu, Shigeru Yutani, Mayumi Kawamoto, Masamichi Kojiro, Kyogo Itoh; CD4+ hepatic cancer-specific cytotoxic T lymphocytes in patients with hepatocellular carcinoma. Cell. Immunol. 177:176-181(1997) PubMed=9416778; DOI=10.1016/S0024-3205(97)01010-2 Masaru Shoji, Tokihisa Kimura, Kozo Ota, Tohru Yamaji, Miyuki Ishibashi, Masahiro Ohta, Hironobu Sasano, Yutaka Kawarabayasi, Noriko Kimura, Takeharu Funyu, Takefumi Mori, Takayuki Sahata; Genotype analysis of prepro-vasopressin signal peptide in vasopressin-producing and -non-producing lung tumors. Life Sci. 61:2561-2566(1997) PubMed=9538136; DOI=10.3892/ijo.12.5.1103 Toshiyuki Takaki, Akio Hiraki, Akiko Uenaka, Shinya Gomi, Kyogo Itoh, Heiichiro Udono, Akira Shibuya, Takao Tsuji, Sadayoshi Sekiguchi, Eiichi Nakayama; Variable expression on lung cancer cell lines of HLA-A2-binding MAGE-3 peptide recognized by cytotoxic T lymphocytes. Int. J. Oncol. 12:1103-1109(1998) PubMed=16105816; DOI=10.1158/0008-5472.CAN-05-0331 Yoshiaki Nagai, Hitoshi Miyazawa, Huqun No_last_name, Tomoaki Tanaka, Kiyoshi Udagawa, Motoyasu Kato, Shunichiro Fukuyama, Akemi Yokote, Kunihiko Kobayashi, Minoru Kanazawa, Koichi Hagiwara; Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp. Cancer Res. 65:7276-7282(2005) PubMed=22313637; DOI=10.4161/cbt.19238 Miyako Takata, Hiroki Chikumi, Naomi Miyake, Kaori Adachi, Yasunobu Kanamori, Akira Yamasaki, Tadashi Igishi, Naoto Burioka, Eiji Nanba, Eiji Shimizu; Lack of AKT activation in lung cancer cells with EGFR mutation is a novel marker of cetuximab sensitivity. Cancer Biol. Ther. 13:369-378(2012) |